Ambience Healthcare Expands “Chart Awareness” Across Its Intelligence Platform

Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization

SPT Labtech and BellBrook Labs Introduce High-Throughput Screening Platform for Cancer Research

Certara Introduces CRF Creator Module in Pinnacle 21® Enterprise Plus for Faster Clinical Study Start-Up in Drug Development

New module streamlines standardized CRF (case report form) design and EDC build to help clinical teams start studies faster.

Innovate UK awards over £300k SMART grant to Exeter HealthTech Research Centre and Sanome to advance AI-enabled early detection of hospital-acquired infections

Firstsource and Prosper AI Partner to Advance Healthcare Revenue Cycle Management with Next-Level Voice AI Capabilities

Ambience Healthcare Partners with MultiCare Health System on Enterprise Rollout of AI Platform

Cirena Launches High-Purity Long RNA to Accelerate CRISPR and Genome-Editing Research

Cirena has announced its public launch following successful delivery of high-quality long RNA to leading academic and pharmaceutical research teams across the U.S., Europe, and Japan.

Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica

InSysBio to announce a new collaborative project with BeOne Medicines

The project aims at Quantitative Systems Pharmacology modeling of a T-cell engager to identify first-in-human dose and predict optimal step-up dosing regimen

Kayentis and Ametris join forces to deliver integrated eCOA solution measuring and improving wearable technology adherence in clinical trials

Revecore Reports Record Growth in 2025 as Health Systems Intensify Focus on Revenue Cycle Performance

Epigenica Launches EpiFinder™ Analysis Service, a Fully Managed Platform for Fast and Reliable Epigenomic Insights

Epigenica AB announces the launch of its EpiFinder™ Analysis Service, a fully managed, high-throughput platform.

Astoriom Acquires Precision Stability Storage

• Acquisition strengthens Astoriom’s stability storage capabilities to meet increasing demand across North America • Offers reliable, compliant, and accessible solutions to advance scientific discovery and product development

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

Life Sciences Consulting Leader Validates Science-Based Climate Commitments, Reducing Emissions Across Its Global Operations

Ceryx Medical (Ceryx) appoints leading MedTech executive Mark Strong as Non-Executive Director

Ceryx has strengthened its Board of Directors with the appointment of Mark Strong.

START Appoints Dr. Navid Hafez as Director of Clinical Research at Its New Los Angeles Site

Dr. Hafez will lead the new early-phase research site at Los Angeles Cancer Network, one of the nation’s largest and most diverse community-based oncology practices.

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer

4D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory biomarker collaborator in the Phase II DAD-IO clinical study (NCT04724018) led by Dana-Farber Cancer Institute and supported by Gilead Sciences, Inc. This high-profile study is evaluating a novel combination therapy for patients with locally advanced or metastatic urothelial carcinoma (mUC), including bladder cancer, and represents an important step forward in 4D Path’s mission to redefine precision oncology.

CluePoints Appoints New Chief People Officer to Support Next Phase of Global Growth

CluePoints, provider of leading statistical and AI-driven software solutions, has appointed Sinead Godkin as its new Chief People Officer (CPO).